{
    "filename": "S2095177920302045.pdf",
    "content_type": "text/html",
    "file_size": 0,
    "metadata": {
        "identifiers": {
            "doi": "10.1016/j.jpha.2020.03.001",
            "url": "https://dx.doi.org/10.1016/j.jpha.2020.03.001"
        },
        "doi": "10.1016/j.jpha.2020.03.001",
        "title": "Molecular immune pathogenesis and diagnosis of COVID-19",
        "date": 2020,
        "journal": "Journal of Pharmaceutical Analysis",
        "abstract": "Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia with an unusual outbreak in Wuhan, China, in December 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century. In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection.",
        "author": "Xiaowei Li, Manman Geng, Yizhao Peng, Liesu Meng, Shemin Lu",
        "references": "",
        "references_ris": "",
        "links": [],
        "author_conclusions": [],
        "table_captions": [],
        "figure_captions": []
    },
    "sections": {
        "introduction": [
            "Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia with an unusual outbreak in Wuhan, China, in December 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century. In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection."
        ]
    },
    "structured_content": {
        "Abstract": [
            "Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia with an unusual outbreak in Wuhan, China, in December 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century. In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection."
        ]
    },
    "participants": [],
    "statistics": [],
    "keywords": [
        "viral pneumonia",
        "human population",
        "pathogenic coronavirus",
        "present understanding",
        "coronavirus disease",
        "middle east respiratory syndrome coronavirus",
        "molecular immune pathogenesis",
        "general feature",
        "sars cov",
        "pathogenesis",
        "potential therapeutic target",
        "severe acute respiratory syndrome coronavirus",
        "unusual outbreak",
        "novel insight",
        "COVID-19",
        "SARS",
        "brief introduction",
        "mers cov infection",
        "current knowledge"
    ],
    "keyword_relevance": {
        "SARS": 0.34615384615384615,
        "COVID-19": 0.11538461538461539,
        "severe acute respiratory syndrome coronavirus": 0.07692307692307693,
        "viral pneumonia": 0.038461538461538464,
        "human population": 0.038461538461538464,
        "pathogenic coronavirus": 0.038461538461538464,
        "present understanding": 0.038461538461538464,
        "molecular immune pathogenesis": 0.038461538461538464,
        "general feature": 0.038461538461538464,
        "pathogenesis": 0.038461538461538464,
        "potential therapeutic target": 0.038461538461538464,
        "unusual outbreak": 0.038461538461538464,
        "novel insight": 0.038461538461538464,
        "brief introduction": 0.038461538461538464,
        "current knowledge": 0.038461538461538464,
        "coronavirus disease": 0.0,
        "middle east respiratory syndrome coronavirus": 0.0,
        "sars cov": 0.0,
        "mers cov infection": 0.0
    },
    "species": [],
    "summary": [
        "Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia with an unusual outbreak in Wuhan, China, in December 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).",
        "The highly pathogenic SARS-CoV-2 appearing in December 2019 can cause COVID-19 and even death in infected persons.",
        "Coronavirus infections led to damage and infection of the lung, but imbalances and excessive immune responses may cause pneumonia.",
        "RT-PCR and CT scans are the significant methods for the diagnosis of SARS-CoV-2 infection and drugs against SARS-CoV-2 are being developed.",
        "The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century.",
        "The authors provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection."
    ],
    "structured_summary": {
        "Introduction": [
            "Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia with an unusual outbreak in Wuhan, China, in December 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."
        ],
        "Results": [
            "The highly pathogenic SARS-CoV-2 appearing in December 2019 can cause COVID-19 and even death in infected persons.",
            "Coronavirus infections led to damage and infection of the lung, but imbalances and excessive immune responses may cause pneumonia.",
            "RT-PCR and CT scans are the significant methods for the diagnosis of SARS-CoV-2 infection and drugs against SARS-CoV-2 are being developed.",
            "The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century."
        ],
        "Conclusion": [
            "The authors provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection."
        ]
    },
    "reference_links": [],
    "facts": [
        "Coronavirus disease 2019 is a kind of viral pneumonia with an unusual outbreak",
        "which is caused by severe acute respiratory syndrome coronavirus 2",
        "The emergence of SARS-CoV-2 has been marked as the third introduction",
        "which may be helpful in offering novel insights",
        "highly pathogenic SARS-CoV-2 appearing in December 2019 can cause COVID-19",
        "Coronavirus infections led to damage and infection of the lung",
        "CT scans are the significant methods for the diagnosis of SARS-CoV-2 infection and drugs"
    ],
    "claims": [
        "In this minireview, we provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection"
    ],
    "findings": [],
    "processes": [],
    "key_statements": [
        "The highly pathogenic SARS-CoV-2 appearing in December 2019 can cause COVID-19 and even death in infected persons",
        "RT-PCR and CT scans are the significant methods for the diagnosis of SARS-CoV-2 infection and drugs against SARS-CoV-2 are being developed",
        "Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia with an unusual outbreak in Wuhan, China, in December 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)",
        "The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century",
        "We provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection"
    ],
    "top_statements": [
        "The highly pathogenic SARS-CoV-2 appearing in December 2019 can cause COVID-19 and even death in infected persons",
        "RT-PCR and CT scans are the significant methods for the diagnosis of SARS-CoV-2 infection and drugs against SARS-CoV-2 are being developed",
        "Coronavirus disease 2019 (COVID-19) is a kind of viral pneumonia with an unusual outbreak in Wuhan, China, in December 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)",
        "The emergence of SARS-CoV-2 has been marked as the third introduction of a highly pathogenic coronavirus into the human population after the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) in the twenty-first century",
        "We provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection"
    ],
    "headline": "We provide a brief introduction of the general features of SARS-CoV-2 and discuss current knowledge of molecular immune pathogenesis, diagnosis and treatment of COVID-19 on the base of the present understanding of SARS-CoV and MERS-CoV infections, which may be helpful in offering novel insights and potential therapeutic targets for combating the SARS-CoV-2 infection",
    "contexts": [],
    "abbreviations": {}
}
